10x Genomics, Inc. Quarterly Cost of Revenue in USD from Q3 2018 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary: 10x Genomics, Inc. quarterly/annual Cost of Revenue history and growth rate from Q3 2018 to Q2 2024.
10x Genomics, Inc. Cost of Revenue for the quarter ending June 30, 2024 was $48.9M, a 3.55% increase year-over-year.
10x Genomics, Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $223M, a 48.6% increase year-over-year.
10x Genomics, Inc. annual Cost of Revenue for 2023 was $209M, a 74% increase from 2022.
10x Genomics, Inc. annual Cost of Revenue for 2022 was $120M, a 62.5% increase from 2021.
10x Genomics, Inc. annual Cost of Revenue for 2021 was $74.1M, a 26.7% increase from 2020.

Cost of Revenue, Trailing 12 Months (USD)

Cost of Revenue, Quarterly (USD)

Cost of Revenue, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$223M	$48.9M	+$1.68M	+3.55%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$222M	$48.1M	+$12.2M	+34%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-04-30
Q4 2023	$209M	$68.2M	+$31.4M	+85.2%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-15
Q3 2023	$178M	$58.1M	+$27.7M	+91.3%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-03
Q2 2023	$150M	$47.2M	+$19.5M	+70.4%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	$131M	$35.9M	+$10.4M	+40.9%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-04-30
Q4 2022	$120M	$36.8M	+$9.23M	+33.4%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-15
Q3 2022	$111M	$30.4M	+$5.86M	+23.9%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-03
Q2 2022	$105M	$27.7M	+$22.8M	+464%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-04
Q1 2022	$82.5M	$25.5M	+$8.42M	+49.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-04
Q4 2021	$74.1M	$27.6M	+$8.7M	+46%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-15
Q3 2021	$65.4M	$24.5M	+$10.1M	+70.1%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	$55.3M	$4.92M	-$5.14M	-51.1%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-09
Q1 2021	$60.4M	$17.1M	+$1.95M	+12.9%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	$58.5M	$18.9M	+$2.32M	+14%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-16
Q3 2020	$56.2M	$14.4M	-$1.07M	-6.91%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-05
Q2 2020	$57.2M	$10.1M	-$4.95M	-33%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-06
Q1 2020	$62.2M	$15.1M	+$1.14M	+8.19%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-07
Q4 2019	$61M	$16.6M			Oct 1, 2019	Dec 31, 2019	10-K	2022-02-18
Q3 2019		$15.5M	+$10.2M	+195%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12
Q2 2019		$15M			Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-12
Q1 2019		$14M			Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-12
Q3 2018		$5.24M			Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.